Volume 19, Number 2—February 2013

Dispatch

Macrolide- and Rifampin-Resistant Rhodococcus equi on a Horse Breeding Farm, Kentucky, USA

Alexandra J. Burton, Steeve Giguère , Tracy L. Sturgill, Londa J. Berghaus, Nathan M. Slovis, Jeremy L. Whitman, Court Levering, Kyle R. Kuskie, and Noah D. Cohen

Author affiliations: Author affiliations: University of Georgia, Athens, Georgia, USA (A.J. Burton, S. Giguère, T.L. Sturgill, L.J. Berghaus); Hagyard Equine Medical Institute, Lexington, Kentucky, USA (N.M. Slovis); Equine Medical Associates, Lexington (J.L. Whitman, C. Levering); Texas A & M University, College Station, Texas, USA (K.R. Kuskie, N.D. Cohen)

Main Article

Figure 1

Figure 1. . Dendrogram and virtual gel repetitive sequence–based PCR fingerprint patterns of foal and air (barn and paddock)–derived isolates of Rhodococcus equi on horse breeding farm, Kentucky, USA, 2010. Macrolide and rifampin susceptibility (S) or resistance (R) are indicated. A indicates the main cluster of drug-resistant isolates (5 foal and 1 air).

Main Article

1Current affiliation: Kalon Biotherapeutics LLC, College Station, Texas, USA.

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.